Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients

Statins are associated with a reduced risk of hepatocellular carcinoma (HCC) and have the potential to be an adjuvant agent for HCC. In this study, we examined whether statin use is associated with additional benefits among patients who received curative treatments (CTs) such as surgery, percutaneou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Li-Li, Hsieh, Mao-Chih, Chow, Jyh-Ming, Liu, Shing-Hwa, Chang, Chia-Lun, Wu, Szu-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023877/
https://www.ncbi.nlm.nih.gov/pubmed/27603355
http://dx.doi.org/10.1097/MD.0000000000004639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023877/
https://www.ncbi.nlm.nih.gov/pubmed/27603355
http://dx.doi.org/10.1097/MD.0000000000004639

Ejemplares similares